2023
Incarceration and screen-detectable cancer diagnosis among adults in Connecticut
Richman I, Soulos P, Lin H, Aminawung J, Oladeru O, Puglisi L, Wang E, Gross C. Incarceration and screen-detectable cancer diagnosis among adults in Connecticut. Journal Of The National Cancer Institute 2023, 116: 485-489. PMID: 37991935, PMCID: PMC10919339, DOI: 10.1093/jnci/djad242.Peer-Reviewed Original ResearchEstimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States.
Richman I, Long J, Soulos P, Wang S, Gross C. Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States. Annals Of Internal Medicine 2023, 176: 1172-1180. PMID: 37549389, PMCID: PMC10623662, DOI: 10.7326/m23-0133.Peer-Reviewed Original ResearchConceptsCumulative incidenceBreast cancerBreast cancer screeningUnscreened womenOlder womenCancer screeningBreast cancer-specific deathBreast cancer overdiagnosisService Medicare claimsRetrospective cohort studyCancer-specific deathBreast cancer deathsWomen 70 yearsHarms of overdiagnosisNational Cancer InstituteBreast cancer diagnosisCohort studyCancer overdiagnosisCancer deathSEER programMedicare claimsCancer InstituteOverdiagnosisGreater incidenceCancer
2022
Lost to follow up?: A qualitative study of why some patients do not pursue lung cancer screening
Richman IB, Prasad TV, Gross CP. Lost to follow up?: A qualitative study of why some patients do not pursue lung cancer screening. Preventive Medicine Reports 2022, 29: 101909. PMID: 35911579, PMCID: PMC9326340, DOI: 10.1016/j.pmedr.2022.101909.Peer-Reviewed Original ResearchLung cancer screeningCancer screeningSafety-net primary care practicesPrimary care practicesEligible adultsLung cancerLack of knowledgeHigh riskNational guidelinesPatientsCare practicesScreeningImportant barriersAdultsSmall proportionQualitative studyImportant populationSemi-structured interviewsParticipantsCancerMonthsInsurance Coverage Mandates and the Adoption of Digital Breast Tomosynthesis
Richman IB, Long JB, Kyanko KA, Xu X, Gross CP, Busch SH. Insurance Coverage Mandates and the Adoption of Digital Breast Tomosynthesis. JAMA Network Open 2022, 5: e224208. PMID: 35333358, PMCID: PMC8956980, DOI: 10.1001/jamanetworkopen.2022.4208.Peer-Reviewed Original ResearchConceptsCoverage mandateCohort studyBreast cancerPocket paymentsDigital breast tomosynthesisInsurance coveragePoints 2 yearsAffordable Care ActMAIN OUTCOMEScreening mammogramsStudy periodDirect costsBreast tomosynthesisPatient ProtectionCare ActWomenCancerAssociationYearsPrivate insurersPatientsCost sharing
2021
Comparative Effectiveness of Digital Breast Tomosynthesis and Mammography in Older Women
Upneja A, Long JB, Aminawung JA, Kyanko KA, Kunst N, Xu X, Busch SH, Gross CP, Richman IB. Comparative Effectiveness of Digital Breast Tomosynthesis and Mammography in Older Women. Journal Of General Internal Medicine 2021, 37: 1870-1876. PMID: 34595682, PMCID: PMC8483166, DOI: 10.1007/s11606-021-07132-6.Peer-Reviewed Original ResearchConceptsWomen 75Older womenBreast cancerAdditional cancersSubsequent imagingWomen 67Stage ITime of diagnosisEarly-stage cancerHigh rateCancer detectionConclusionsBreast cancerPrior cancerPotential confoundersScreening outcomesHealth outcomesService beneficiariesComparative effectivenessScreening mammogramsAge groupsCancerLogistic regressionResultsOur studyWomenBreast tomosynthesis
2020
Use and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance
Kunst N, Long JB, Xu X, Busch SH, Kyanko KA, Richman IB, Gross CP. Use and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance. JAMA Internal Medicine 2020, 180: 799-801. PMID: 32202606, PMCID: PMC7147248, DOI: 10.1001/jamainternmed.2020.0262.Peer-Reviewed Original Research
2018
Cost-Effectiveness Analyses of the 21-Gene Assay in Breast Cancer: Systematic Review and Critical Appraisal.
Wang SY, Dang W, Richman I, Mougalian SS, Evans SB, Gross CP. Cost-Effectiveness Analyses of the 21-Gene Assay in Breast Cancer: Systematic Review and Critical Appraisal. Journal Of Clinical Oncology 2018, 36: 1619-1627. PMID: 29659329, PMCID: PMC5978470, DOI: 10.1200/jco.2017.76.5941.Peer-Reviewed Original ResearchConceptsCost-effectiveness analysisChemotherapy useBreast cancerEarly-stage breast cancerStudy designIncremental cost-effectiveness ratioODX recurrence scoreHigh-risk patientsLow-risk patientsRisk of biasCost-effectiveness ratioCost-effectiveness estimatesIndustry fundingDistant recurrenceIndustry-funded studiesClinical characteristicsTumor characteristicsRecurrence scoreChemotherapy decisionsScore groupClinical practiceSystematic reviewODXPatientsCancer
2017
Aspirin for Primary Prevention
Richman IB, Owens DK. Aspirin for Primary Prevention. Medical Clinics Of North America 2017, 101: 713-724. PMID: 28577622, DOI: 10.1016/j.mcna.2017.03.004.BooksMeSH KeywordsAge FactorsAspirinCardiovascular DiseasesColorectal NeoplasmsDiabetes MellitusGastrointestinal HemorrhageHumansHypertensionLipidsMyocardial InfarctionPlatelet Aggregation InhibitorsPractice Guidelines as TopicPrimary PreventionRacial GroupsRisk AssessmentRisk FactorsSex FactorsSmokingStrokeConceptsColorectal cancerPrimary preventionCardiovascular diseaseUS Preventive Services Task ForceNonfatal myocardial infarctionCardiovascular disease riskAdults age 50Intracranial bleedingOlder patientsMyocardial infarctionSelect populationAge 50AspirinAdults 60Disease riskAvailable evidenceRiskCancerDiseasePreventionTask ForceBleedingInfarctionPatientsStroke
2016
Breast Density Notification Legislation and Breast Cancer Stage at Diagnosis: Early Evidence from the SEER Registry
Richman I, Asch SM, Bendavid E, Bhattacharya J, Owens DK. Breast Density Notification Legislation and Breast Cancer Stage at Diagnosis: Early Evidence from the SEER Registry. Journal Of General Internal Medicine 2016, 32: 603-609. PMID: 27844260, PMCID: PMC5442000, DOI: 10.1007/s11606-016-3904-y.Peer-Reviewed Original ResearchConceptsBreast density notification legislationProportion of womenBreast cancer stageCancer stageBreast cancerMetastatic diseaseEnd Results (SEER) Program registryTime of diagnosisInvasive breast cancerBreast density notification lawsSEER registryControl stateDuctal carcinomaInvasive cancerProgram registryAge 40Potential confoundingLimited followSignificant associationIntervention statesDense breastsResultsOur studyCancerDiagnosisEarly detection